Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cisplatin and radiotherapy].

E Dühmke

    Strahlentherapie
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Cis-platinum (CDDP) enhances ionizing radiation

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Not Available].

    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
    Same author

    Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group.

    Annals of oncology : official journal of the European Society for Medical Oncology·2006
    Same author

    The Application of Photofrin II as a sensitizing agent for ionizing radiation--a new approach in tumor therapy?

    Current medicinal chemistry·2005
    Same author

    Early time course of neointima formation and vascular remodelling following percutaneous coronary intervention and vascular brachytherapy of in-stent restenotic lesions as assessed by intravascular ultrasound analysis.

    Zeitschrift fur Kardiologie·2005
    Same author

    A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).

    Annals of oncology : official journal of the European Society for Medical Oncology·2004
    Same author

    Suboccipital lateral injection of intrathecal chemotherapy in a patient with mantle cell lymphoma.

    Onkologie·2004
    Same journal

    Local sulfonamide pretreatment in the radium therapy of portiocarcinoma.

    Strahlentherapie·2010
    Same journal

    About an influence of the field shape on the can size when the tube is standing and moving.

    Strahlentherapie·2010
    Same journal

    Treatment of biological tissue with focused ultrasound.

    Strahlentherapie·2010
    Same journal

    About the negative threshold of ultraviolet erythema (studies on 105 people.).

    Strahlentherapie·2010
    Same journal

    UV rays and cell interface (AC measurements on frog skin irradiated with UV light.).

    Strahlentherapie·2010
    Same journal

    Tension measurements on tissues.

    Strahlentherapie·2010
    See all related articles

    Area of Science:

    • Oncology
    • Radiation Oncology
    • Medical Chemistry

    Context:

    • Ionizing radiation's cytotoxic effects are potentiated by platinum-based drugs.
    • This radiosensitization is particularly effective under hypoxic conditions.
    • Drug-DNA interactions and inhibition of DNA repair are key mechanisms.

    Purpose:

    • To evaluate the synergistic effects of cis-platinum (CDDP) and radiotherapy (RT).
    • To assess the therapeutic potential and side effects of combined CDDP and RT.
    • To explore optimization strategies for combined platinum-based chemotherapy and radiation therapy.

    Summary:

    • CDDP and its derivatives enhance radiation therapy's cytotoxic effects, especially in hypoxic environments.
    • Animal studies show therapeutic gains, with a factor of 1.7 in C3H mammary carcinoma.

    Related Experiment Videos

  • Clinical pilot studies in head and neck cancers show comparable results to sequential treatments, with manageable side effects.

    • Impact:

    • Combined CDDP and RT demonstrates therapeutic potential in preclinical and clinical settings.
    • Optimization of dosage and drug selection may further improve treatment outcomes.
    • Current side effects appear clinically manageable, with no significant long-term adverse effects reported.